Kailera Therapeutics, Inc. (KLRA)
Nasdaq: KLRA · Pharmaceutical Preparations · filing with the SEC since 2025
Income statement, as filed
In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal quarter | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|
| Period ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 |
| Report filed | Nov 4, 2026 | Aug 12, 2026 | May 26, 2026 |
| Research and development | 84,667,000 | 101,061,000 | 70,873,000 |
| General and administrative | 21,669,000 | 20,312,000 | 13,787,000 |
| Total operating expenses | 106,336,000 | 121,373,000 | 84,660,000 |
| Operating income | -106,336,000 | -121,373,000 | -84,660,000 |
| Interest income (expense), net | 10,611,000 | 9,994,000 | 5,716,000 |
| Other income (expense), net | 60,000 | 72,000 | 5,795,000 |
| Total non-operating income (expense) | 10,671,000 | 10,066,000 | · |
| Net income | -95,665,000 | -111,307,000 | -78,865,000 |
| Earnings per share, basic | -0.74 | -1.09 | -3,650.00 |
| Earnings per share, diluted | -0.74 | -1.09 | -3,650.00 |
| Weighted average shares, basic | 129,653,008 | 102,226,608 | 21,607 |
| Weighted average shares, diluted | 129,653,008 | 102,226,608 | 21,607 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Each quarter is three months. A fourth quarter prints only where the company tagged its three months on their own; the whole year is in the annual view.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding